Testing effectiveness (Phase 2)Study completedNCT06283550
What this trial is testing
Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy
Who this might be right for
Chronic Hand Eczema
Innovaderm Research Inc. 82